Pityriasis versicolor: an update on pharmacological treatment optionsGUPTAT, Aditya K; LYONS, Danika C. A.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 12, pp 1707-1713, issn 1465-6566, 7 p.Article

Interleukin 17, Interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: A case- controlled study on eighty-four patientsELELA, Mostafa Abou; HEGAZY, Rehab A; FAWZY, Marwa Mohamed et al.EJD. European journal of dermatology. 2013, Vol 23, Num 3, pp 350-355, issn 1167-1122, 6 p.Article

Provoking factors, including chemicals, in Dutch patients with vitiligoVRIJMAN, C; HOSSEINPOUR, D; BAKKER, J. G et al.British journal of dermatology (1951). 2013, Vol 168, Num 5, pp 1003-1011, issn 0007-0963, 9 p.Article

Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laserHYUN HEE CHO; MIRA CHOI; SOYUN CHO et al.Journal of dermatological treatment. 2013, Vol 24, Num 4, pp 292-296, issn 0954-6634, 5 p.Article

Serum levels of functional T-regs in vitiligo: our experience and mini-review of the literatureRICHETTA, Antonio; D'EPIRO, Sara; ZANNIELLO, Ramona et al.EJD. European journal of dermatology. 2013, Vol 23, Num 2, pp 154-159, issn 1167-1122, 6 p.Article

Anomalies pigmentaires induites par les traitements anticancéreux. Deuxième partie: les thérapies ciblées = Pigmentary disorders induced by anticancer agents. Part II: Targeted therapiesSIBAUD, V; ROBERT, C.Annales de dermatologie et de vénéréologie. 2013, Vol 140, Num 4, pp 266-273, issn 0151-9638, 8 p.Article

A Case of Argyria: Multiple Forms of Silver Ingestion in a Patient With Comorbid Schizoaffective DisorderSCHRAUBEN, Sarah J; BHANUSALI, Dhaval G; SHEETS, Stuart et al.Cutis (New York, NY). 2012, Vol 89, Num 5, pp 221-224, issn 0011-4162, 4 p.Article

A pigmented lesion on the footSMITH, E. V; MADAN, V; JOSHI, A et al.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 1, pp 84-86, issn 0307-6938, 3 p.Article

An unusual cause of a pigmented lesionPALANIVEL, J. A; MURPHY, J. G; MILLINGTON, G. W. M et al.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 7, pp 819-821, issn 0307-6938, 3 p.Article

Practical advice regarding problematic pigmented lesionsELSTON, Dirk.Journal of the American Academy of Dermatology. 2012, Vol 67, Num 1, pp 148-155, issn 0190-9622, 8 p.Article

Reticulate hyperpigmentation of the vulvaTSAKOK, Teresa; SHETH, Nisith; SUCHAK, Ravi et al.Archives of dermatology (1960). 2012, Vol 148, Num 1, issn 0003-987X, 115, 118 [2 p.]Article

Association between CDK5PAP1 polymorphisms and susceptibility to vitiligo in the Korean populationSHIN, Min-Kyung; UHM, Yoon-Kyung; LEE, Jong-Ho et al.EJD. European journal of dermatology. 2012, Vol 22, Num 4, pp 495-499, issn 1167-1122, 5 p.Article

HLA Alleles and Amino-Acid Signatures of the Peptide-Binding Pockets of HLA Molecules in VitiligoSINGH, Archana; SHARMA, Pankaj; RANI, Rajni et al.Journal of investigative dermatology. 2012, Vol 132, Num 1, pp 124-134, issn 0022-202X, 11 p.Article

Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinicHAWRYLUK, Elena B; SOBER, Arthur J; PIRIS, Adriano et al.Journal of the American Academy of Dermatology. 2012, Vol 67, Num 4, pp 727-735, issn 0190-9622, 9 p.Article

New insights in segmental vitiligo: case report and review of theoriesVAN GEEL, N; MOLLET, I; BROCHEZ, L et al.British journal of dermatology (1951). 2012, Vol 166, Num 2, pp 240-246, issn 0007-0963, 7 p.Article

Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot studyKROON, Marije W; WIND, Bas S; MEESTERS, Arne A et al.Journal of dermatological treatment. 2012, Vol 23, Num 5, pp 339-344, issn 0954-6634, 6 p.Article

Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligoKARADAG, A. S; TUTAL, E; ERTUGRUL, D. T et al.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 1, pp 62-64, issn 0307-6938, 3 p.Article

Maladie de Dowling-Degos étendue après PUVA thérapie prolongée = Extensive Dowling-Degos disease following long term PUVA therapyKORT KHADDAR, R; KOUBAA MAHJOUB, W; ZARAA, I et al.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 1, pp 54-57, issn 0151-9638, 4 p.Article

Clinical significance of Koebner phenomenon in vitiligoGEEL, N. Van; SPEECKAERT, R; DE WOLF, J et al.British journal of dermatology (1951). 2012, Vol 167, Num 5, pp 1017-1024, issn 0007-0963, 8 p.Article

Risk factors in facial hyperpigmentation in Maghrebian population ― a case―control studyBENCHIKHI, H; ATIDE, N; JROUNDI, I et al.International journal of cosmetic science. 2012, Vol 34, Num 5, pp 477-480, issn 0142-5463, 4 p.Article

Ineffective topical treatment of vitiligo with Cucumis melo extractsSCHALLREUTER, Karin Uta; PANSKE, Angela; CHIUCHIARELLI, Georgia et al.International journal of dermatology. 2011, Vol 50, Num 3, pp 374-375, issn 0011-9059, 2 p.Article

Linear and whorled nevoid hypermelanosisMEHTA, Vandana; VASANTH, Vani; BALACHANDRAN, Chandrashekaran et al.International journal of dermatology. 2011, Vol 50, Num 4, pp 491-492, issn 0011-9059, 2 p.Article

Perifollicular inflammatory infiltrate in vitiligoEL-DIN ANBAR, Tag; ABDEL-RAOUF, H; AWAD, S. S et al.EL-DIN ANBAR, Tag; International journal of dermatology. 2011, Vol 50, Num 2, pp 234-237, issn 0011-9059, 4 p.Article

Successful treatment with narrowband UVB phototherapy in prurigo pigmentosa associated with pregnancyMIN SU JANG; JAE WOO BAEK; DONG YOUNG KANG et al.EJD. European journal of dermatology. 2011, Vol 21, Num 4, pp 634-635, issn 1167-1122, 2 p.Article

Hypopigmentation prétibiale prurigineuse antillaise = Pruritic pretibial hypopigmentation in West Indian patientsQUILLET, C; DERANCOURT, C; DESCHAMPS, L et al.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 1, pp 55-57, issn 0151-9638, 3 p.Article